Syntone Ventures LLC - 10%+ Owner at Outlook Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
OTLK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Syntone Ventures LLC since 11 Mar 2025

Holdings reported by Syntone Ventures LLC for Outlook Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,705,438 $716,284 $0.4200 15 Apr 2024 Direct
Warrant (Right to Buy) 1,071,429 15 Apr 2024 Direct Common Stock

Transactions reported by Syntone Ventures LLC for Outlook Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.